LDL-C achievement in patients with coronary artery disease: a study protocol for the EDHIPO-MARCA retrospective registry
This study was approved by the Comité de Ética en Investigación Biomédica of Fundación Valle del Lili, the coordinating institution and creator of the study protocol. Each participating centre will obtain approval from its local ethics committee prior to data collection. Data will be collected in a de-identified manner, ensuring confidentiality. In accordance with Colombian Resolution 8430, this study is classified as 'no-risk', and informed consent was not required. The findings will be disseminated through scientific events and published in international peer-reviewed journals to contribute to cardiovascular disease management and public health policies.
Authors
- Dora I. Molina (ORCID: https://orcid.org/0000-0002-8006-915X)
- Juan Pablo Arango-Ibañez (ORCID: https://orcid.org/0000-0003-3601-3279)
- Álvaro J. Ruiz (ORCID: https://orcid.org/0000-0001-6528-4268)
- Brayan Daniel Córdoba‐Melo (ORCID: https://orcid.org/0000-0003-2401-6413)
- Juan Esteban Gomez-Mesa
- Santiago Posso-Marín
Institutions
- University of Caldas (CO)
- Pontificia Universidad Javeriana (CO)
- Fundación Valle del Lili (CO)
- Icesi University (CO)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-100569
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi